Published in Am J Transplant on August 21, 2009
Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant (2011) 1.84
Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection. Transplantation (2011) 1.42
Development of organ-specific donor risk indices. Liver Transpl (2012) 1.26
Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infection. Clin J Am Soc Nephrol (2010) 1.03
New Solutions to Reduce Discard of Kidneys Donated for Transplantation. J Am Soc Nephrol (2015) 0.75
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA (2005) 4.16
Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med (2008) 2.83
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
The disease profile of Texas prison inmates. Ann Epidemiol (2000) 2.65
Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med (2004) 2.08
Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc Nephrol (2006) 1.92
The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group. Ann Intern Med (1998) 1.81
Health behind bars: utilization and evaluation of medical care among jail inmates. J Community Health (1999) 1.68
Drug use and risk of bloodborne infections: a survey of female prisoners in British Columbia. Can J Public Health (2005) 1.65
Estimated benefits of transplantation of kidneys from donors at increased risk for HIV or hepatitis C infection. Am J Transplant (2007) 1.63
Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs. Am J Transplant (2007) 1.51
Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation. Am J Transplant (2007) 1.42
Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention. MMWR Recomm Rep (1994) 1.40
A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis (2008) 1.37
Viral nucleic acid testing (NAT) and OPO-level disposition of high-risk donor organs. Am J Transplant (2009) 1.00
Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation (2008) 0.97
Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list. Am J Transplant (2005) 0.93
Informing candidates for transplantation about donor risk factors. N Engl J Med (2008) 0.92
Enhancing transplant safety: a new era in the microbiologic evaluation of organ donors? Am J Transplant (2007) 0.87
Efficacy of home-based peer counselling to promote exclusive breastfeeding: a randomised controlled trial. Lancet (1999) 4.52
Is the defensive use of diagnostic tests good for patients, or bad? Med Decis Making (1998) 4.17
Cost-effectiveness analysis in a setting of budget constraints--is it equitable? N Engl J Med (1996) 4.13
A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med (1992) 3.56
Direct sale of sildenafil (Viagra) to consumers over the Internet. N Engl J Med (1999) 3.42
The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant (2010) 3.35
Prescription drug use and self-prescription among resident physicians. JAMA (1998) 3.20
Hemodialysis vascular access morbidity. J Am Soc Nephrol (1996) 3.09
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50
Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med (2001) 2.27
Correlated size variations in human visual cortex, lateral geniculate nucleus, and optic tract. J Neurosci (1997) 2.26
Outcomes evaluation of a comprehensive intervention program for asthmatic children enrolled in medicaid. Pediatrics (2000) 2.18
Mortality and cardiovascular disease among older live kidney donors. Am J Transplant (2014) 2.16
Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet (1998) 2.07
Do persons with dementia vote? Neurology (2002) 2.04
Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J Clin Epidemiol (1996) 2.04
Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant (2015) 2.03
Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis. Transpl Infect Dis (2015) 2.00
A national study of ethics committees. Am J Bioeth (2001) 1.90
Classifying general medicine readmissions. Are they preventable? Veterans Affairs Cooperative Studies in Health Services Group on Primary Care and Hospital Readmissions. J Gen Intern Med (1996) 1.89
Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am J Transplant (2008) 1.81
The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group. Ann Intern Med (1998) 1.81
Are supplementary services provided during methadone maintenance really cost-effective? Am J Psychiatry (1997) 1.81
Physician characteristics associated with decisions to withdraw life support. Am J Public Health (1995) 1.76
Barriers to office-based screening sigmoidoscopy: does reimbursement cover costs? Ann Intern Med (1999) 1.74
Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr (1993) 1.60
Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant (2008) 1.57
Biases in how physicians choose to withdraw life support. Lancet (1993) 1.52
Serum antibody as a marker of protection against natural rotavirus infection and disease. J Infect Dis (2000) 1.51
Stimulated renal tubular epithelial cells induce anergy in CD4+ T cells. Kidney Int (1993) 1.50
Predicting non-elective hospital readmissions: a multi-site study. Department of Veterans Affairs Cooperative Study Group on Primary Care and Readmissions. J Clin Epidemiol (2000) 1.48
Health and health care among housestaff in four U.S. internal medicine residency programs. J Gen Intern Med (2000) 1.46
Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant (2009) 1.42
Prenatal screening for toxoplasmosis. Obstet Gynecol (1997) 1.41
Residency reform: opportunity knocks. J Gen Intern Med (1991) 1.40
Pericardial abscess extending from mitral vegetation: an unusual complication of infective endocarditis. Am Heart J (1989) 1.39
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group. J Antimicrob Chemother (1999) 1.39
The illusion of deterministic rules. Ann Intern Med (1997) 1.39
A comparison of the survival of shipped and locally transplanted cadaveric renal allografts. N Engl J Med (2001) 1.37
Treatment of PTLD with rituximab or chemotherapy. Am J Transplant (2006) 1.33
Arterial hypertension and renal allograft survival. JAMA (2000) 1.33
Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr (1999) 1.26
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis. Transpl Infect Dis (2000) 1.22
Timing payments to subjects of mail surveys: cost-effectiveness and bias. J Clin Epidemiol (1995) 1.20
Cursing the darkness: are there limits to end-of-life research? J Gen Intern Med (1998) 1.19
Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database. Ann Rheum Dis (2006) 1.14
Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant (2006) 1.14
Measuring patient expectations: does the instrument affect satisfaction or expectations? Med Care (2001) 1.14
A multicentre randomised controlled trial of an intervention to improve the accuracy of linear growth measurement. Arch Dis Child (2004) 1.13
Projections of hypertension-related renal disease in middle-aged residents of the United States. JAMA (1993) 1.11
A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients. Am J Transplant (2012) 1.11
Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int (2001) 1.10
Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial. Am J Transplant (2009) 1.10
EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial. Am J Transplant (2008) 1.08
Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study. Transpl Infect Dis (2013) 1.06
Industry-sponsored research. University of Pennsylvania Research Ethics Working Group. Lancet (2001) 1.06
Do nonpatients underestimate the quality of life associated with chronic health conditions because of a focusing illusion? Med Decis Making (2001) 1.05
Primary care physicians' decisions to perform flexible sigmoidoscopy. J Gen Intern Med (1999) 1.05
Caregivers' preferences for the treatment of patients with Alzheimer's disease. Neurology (2000) 1.02
Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction. Am J Transplant (2012) 1.00
Determinants of coronary artery calcification progression in renal transplant recipients. Am J Transplant (2007) 1.00
Inpatient rehabilitation after stroke: a comparison of lengths of stay and outcomes in the Veterans Affairs and non-Veterans Affairs health care system. Med Care (2001) 1.00
Staphylococcus aureus infection of human endothelial cells potentiates Fc receptor expression. J Immunol (1990) 0.99
Obtaining informed consent for clinical pain research: patients' concerns and information needs. Pain (2001) 0.98
Medical specialists prefer to withdraw familiar technologies when discontinuing life support. J Gen Intern Med (1995) 0.98
Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant (2011) 0.98
Cryptococcus albidus and mucormycosis empyema in a patient receiving hemodialysis. South Med J (1993) 0.97
Bone loss after orthotopic liver transplantation. Am J Med (1994) 0.97
A new instrument for residency program evaluation. J Gen Intern Med (1997) 0.97
Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Transpl Infect Dis (2012) 0.96
Predictors of bacteremia in febrile children 3 to 36 months of age. Pediatrics (2000) 0.95
The public's attitudes toward incentives for organ donation. Transplant Proc (1999) 0.95
A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer. Br J Cancer (2005) 0.94
Designing pain research from the patient's perspective: what trial end points are important to patients with chronic pain? Pain Med (2001) 0.94
Testing the reliability of old and new features of a new electronic monitor for metered dose inhalers. Ann Allergy Asthma Immunol (2001) 0.93
Preference for equity as a framing effect. Med Decis Making (2001) 0.93
Prevalence of stress hyperglycemia among patients attending a pediatric emergency department. J Pediatr (1994) 0.92
Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis. J Am Soc Nephrol (1997) 0.92
Public preferences for efficiency and racial equity in kidney transplant allocation decisions. Transplant Proc (1996) 0.92
Transplant center volume and outcomes after liver retransplantation. Am J Transplant (2008) 0.91
Risk of foot complications in long-term diabetic patients with and without ESRD: a preliminary study. ANNA J (1996) 0.91
Risk screening in a medicare/medicaid population administrative data versus self report. J Gen Intern Med (2001) 0.91
Public preferences for prevention versus cure: what if an ounce of prevention is worth only an ounce of cure? Med Decis Making (1998) 0.91
Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy. Acta Psychiatr Scand (2009) 0.90
Does candidemia predict threshold retinopathy of prematurity in extremely low birth weight (</=1000 g) neonates? Pediatrics (2000) 0.90
Changes in causes of death after renal transplantation, 1966 to 1987. Am J Kidney Dis (1991) 0.90
Power analyses for longitudinal study designs with missing data. Stat Med (2007) 0.89
AST/ASTS workshop on increasing organ donation in the United States: creating an "arc of change" from removing disincentives to testing incentives. Am J Transplant (2015) 0.89
How preliminary data affect people's stated willingness to enter a hypothetical randomized controlled trial. J Investig Med (1997) 0.89
A prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction. Transpl Infect Dis (2006) 0.89
Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients. Am J Transplant (2010) 0.88
Measuring community benefits provided by for-profit and nonprofit hospitals. Health Aff (Millwood) (2001) 0.88
BK virus genotype variance and discordant BK viremia PCR assay results. Am J Transplant (2013) 0.88
Evaluation of low density spine software for the assessment of bone mineral density in children. J Bone Miner Res (1998) 0.88
Are preferences for equity over efficiency in health care allocation "all or nothing"? Med Care (2000) 0.88
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment. Pharmacogenomics J (2008) 0.87